Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-04-30T10:37:04.192Z Has data issue: false hasContentIssue false
  • English
  • Français

Markets in Health Care: The Case of Renal Transplantation

Published online by Cambridge University Press:  01 January 2021

Troyen Brennan
Get access Rights & Permissions [Opens in a new window]

Extract

Recent developments in organ procurement have revived the much-debated role of markets in our health care system. The unique American health care system, with its presumption of universality alongside private health insurance and relatively limited federal and state programs, is in many ways consumer-driven today. We certainly tolerate more broad disparities in availability of care and in outcomes of care largely based on socioeconomic status than do many other developed countries, where notions of universal access are supported by broader public financing.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 35 , Issue 2 , Summer 2007 , pp. 249 - 255
Copyright
Copyright © American Society of Law, Medicine and Ethics 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Steinbrook, R., “Public Solicitation of Organ Donors,” New England Journal of Medicine 353, no. 5 (2005): 441–44; Delmonico, F. L., “Exchanging Kidneys – Advances in Living-Donor Transplantation,” New England Journal of Medicine 350 (2004): 1812–4; Truog, R. D., “The Ethics of Organ Donation by Living Donors,” New England Journal of Medicine 353, no. 5 (2005): 444-6.CrossRefGoogle Scholar
See e.g., Epstein, R., Mortal Peril (Chicago: Addison Wellesley, 1997).Google Scholar
Many of the papers outlining these positions are cited in Brennan, T. A., Just Doctoring: Medical Ethics in the Liberal State (Berkeley, CA: University of California Press, 1991).CrossRefGoogle Scholar
Drukker, A., “Payment for Organ Donation: Unacceptable or a Possible Solution?” IPNA 18 (2003): 198–199; Friedlaender, M. M., “The Right to Sell or Buy a Kidney: Are We Failing Our Patients?” The Lancet 359, no. 1: 971-73.Google Scholar
See Delmonico, supra note 1.Google Scholar
See Steinbrook, supra note 1.Google Scholar
Id.Google Scholar
See supra note 3.Google Scholar
Matas, A. J. and Schnitzler, M., “Payment for Living Donor (Vendor) Kidneys: A Cost-Effectiveness Analysis,” American Journal of Transplantation 4, no. 2 (2004): 216–221.CrossRefGoogle Scholar
Goyal, M., Mehta, R. L., Schneiderman, L. J. and Sehgal, A. R., “Economic and Health Consequences of Selling a Kidney in India,” JAMA 288, no. 13 (2002): 1589–92.CrossRefGoogle Scholar
Gawande, A., “Letting People Peddle Their Kidneys Might Save Lives, but the Ethical Price Is Too High,” Slate, 1998, available at <http://www.slate.com/id/3680/> (last visited April 9, 2007).Google Scholar
Brinkley, D., The Great Deluge (New York: Harper Collins, 2006).Google Scholar
Project of the ABIM Foundation, The ACP-ASIM Foundation, and The European Federation of Internal Medicine, “Medical Professionalism in the New Millennium: A Physician Charter,” Annals of Internal Medicine 136, no. 3 (2002): 243–6.CrossRefGoogle Scholar
Harris, J. and Erin, C., “”An Ethically Defensible Market in Organs,” Editorial”, British Medical Journal 325, no. 7356 (2001): 114–115.CrossRefGoogle Scholar